240 related articles for article (PubMed ID: 22392126)
1. Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases.
Ohtakara K; Hayashi S; Nakayama N; Ohe N; Yano H; Iwama T; Hoshi H
J Neurooncol; 2012 May; 108(1):201-9. PubMed ID: 22392126
[TBL] [Abstract][Full Text] [Related]
2. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.
Blonigen BJ; Steinmetz RD; Levin L; Lamba MA; Warnick RE; Breneman JC
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):996-1001. PubMed ID: 19783374
[TBL] [Abstract][Full Text] [Related]
3. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
Donovan EK; Parpia S; Greenspoon JN
Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
[TBL] [Abstract][Full Text] [Related]
4. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
5. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
Milano MT; Grimm J; Niemierko A; Soltys SG; Moiseenko V; Redmond KJ; Yorke E; Sahgal A; Xue J; Mahadevan A; Muacevic A; Marks LB; Kleinberg LR
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):68-86. PubMed ID: 32921513
[TBL] [Abstract][Full Text] [Related]
6. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
[TBL] [Abstract][Full Text] [Related]
7. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.
Minniti G; Clarke E; Lanzetta G; Osti MF; Trasimeni G; Bozzao A; Romano A; Enrici RM
Radiat Oncol; 2011 May; 6():48. PubMed ID: 21575163
[TBL] [Abstract][Full Text] [Related]
9. Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.
Di Perri D; Tanguy R; Malet C; Robert A; Sunyach MP
J Neurooncol; 2020 Sep; 149(3):447-453. PubMed ID: 32979130
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases.
Tanenbaum DG; Buchwald ZS; Jhaveri J; Schreibmann E; Switchenko JM; Prabhu RS; Chowdhary M; Abugideiri M; Pfister NT; Eaton B; Kahn SE; Olson JJ; Shu HG; Crocker IR; Curran WJ; Patel KR
Pract Radiat Oncol; 2020; 10(1):36-43. PubMed ID: 31586666
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: correlation with dose distribution parameters.
Levegrün S; Hof H; Essig M; Schlegel W; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):796-808. PubMed ID: 15183483
[TBL] [Abstract][Full Text] [Related]
12. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic radiation necrosis in brain metastasis patients treated with stereotactic radiosurgery and immunotherapy.
Weingarten N; Kruser TJ; Bloch O
Clin Neurol Neurosurg; 2019 Apr; 179():14-18. PubMed ID: 30784894
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the risk factors in the development of radionecrosis in patients with brain metastases undergoing stereotactic radiotherapy.
Doğan B; Demir H; Işık N; Gunalp G; Günbey HP; Yaprak G
Br J Radiol; 2024 May; 97(1157):1022-1028. PubMed ID: 38426391
[TBL] [Abstract][Full Text] [Related]
15. Radionecrosis (RN) in patients with brain metastases treated with stereotactic radiosurgery (SRS) and immunotherapy.
Andring L; Squires B; Seymour Z; Fahim D; Jacob J; Ye H; Marvin K; Grills I
Int J Neurosci; 2023 Feb; 133(2):186-193. PubMed ID: 33685315
[TBL] [Abstract][Full Text] [Related]
16. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
17. Postoperative stereotactic radiosurgery for patients with resected brain metastases: a volumetric analysis.
Patel RA; Lock D; Helenowski IB; Chandler JP; Tate MC; Bloch O; Sachdev S; Kruser TJ
J Neurooncol; 2018 Nov; 140(2):395-401. PubMed ID: 30084023
[TBL] [Abstract][Full Text] [Related]
18. Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases.
Kohutek ZA; Yamada Y; Chan TA; Brennan CW; Tabar V; Gutin PH; Yang TJ; Rosenblum MK; Ballangrud Å; Young RJ; Zhang Z; Beal K
J Neurooncol; 2015 Oct; 125(1):149-56. PubMed ID: 26307446
[TBL] [Abstract][Full Text] [Related]
19. Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study.
Lehrer EJ; Gurewitz J; Bernstein K; Patel D; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Malouff TD; Ruiz-Garcia H; Patel S; Bonney PA; Hwang L; Yu C; Zada G; Mathieu D; Trudel C; Prasad RN; Palmer JD; Jones BM; Sharma S; Fakhoury KR; Rusthoven CG; Deibert CP; Picozzi P; Franzini A; Attuati L; Lee CC; Yang HC; Ahluwalia MS; Sheehan JP; Trifiletti DM
Cancer; 2022 Apr; 128(7):1429-1438. PubMed ID: 35077586
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts.
Li J; He J; Cai L; Lai M; Hu Q; Ren C; Wen L; Wang J; Zhou J; Zhou Z; Li S; Ye M; Shan C; Chen L; Zhou C
Ann Palliat Med; 2021 Feb; 10(2):2018-2026. PubMed ID: 33549015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]